After years of research and clinical testing, we have developed non-invasive, accurate blood tests for early detection of cancer. By making cancer prevention routine, we enable everyone to take control of their own health. The more people take our breakthrough blood tests, the more lives we can save. Life over cancer.

Hereditary Breast Cancer Risk Test

We test for 15 genes associated with breast cancer risk — not just BRCA.

Get the most comprehensive, affordable test available.

Breast cancer risk is from more than BRCA mutations.

These women all have increased breast cancer risk:

Most breast cancer risk tests on the market today only test for mutations in the BRCA1 and BRCA2 genes.

But the National Comprehensive Care Network (NCCN) and the American College of Medical Geneticists (ACMG) recognize that mutations in several additional genes are associated with an increased risk for hereditary breast cancer.

The CellMax Life Breast Cancer Risk Test looks at 13 additional genes along with BRCA1 & BRCA2 — giving you a more complete understanding of your risk — all for the same price as the BRCA-only tests available.

Knowing your risk can help you be proactive.

Inherited genetic mutations can increase your breast cancer risk up to 17 times.1, 2, 3 CellMax Life offers the most complete breast cancer home test—measuring all genes in national cancer testing guidelines, more affordably than any other test on the market today.

Our Hereditary Breast Cancer Risk Test can help you:


Screen Early and Often

You can work with your doctor on a screening program. This may include starting at a younger age or getting screened more frequently so cancer can be detected early.

Take Precautions

Your doctor may prescribe preventative medication to reduce cancer risk. Individuals at higher risk can benefit from taking FDA-approved drugs to lower the chance of developing certain cancers.

Care for Your Family

Your family members can also determine their risk status and take charge of their health. Parents, siblings and children have up to a 50% chance of carrying the same mutation, putting them at increased risk.

Early cancer detection improves survival rate. 4

While testing positive for inherited mutations indicates an increased risk of breast cancer, detecting such cancers early dramatically improves survival rates.

Breast Cancer Risk

5-Year Survival Rates

How The Test WorksIn 3 simple steps

Purchase your test online and receive a ready-to-use collection kit in the mail.

Step 1

Provide a saliva sample, send back in a pre-paid envelope.

Step 2

Receive your easy-to-read report in 3 to 4 weeks.

Step 3

Talk to your doctor about a personalized health plan.

Who is this test for?

  • Healthy individuals, male and female, who want to know their risk for breast cancer.
  • Individuals with a history of breast or ovarian cancer.
  • Individuals with a relative who has had breast, ovarian or pancreatic cancer.
  • Individuals with a relative who is positive for the BRCA1 or BRCA2 mutations or other mutations associated with increased risk for breast cancer.
  • Individuals in certain ethnic groups (eg Ashkenazi Jewish) that have an increased risk for certain cancers.

What You'll Get

  • A detailed report on the presence of absence of mutations associated with increased cancer risk.
  • Review of test results by board-certified physicians.

Why CellMax Life?

  • CellMax Life is the only diagnostics company with proven technologies to assess cancer risk and detect cancer early when it is most curable.
  • We hold 7 patents, and have been published in leading scientific journals.
  • We perform testing at CLIA-certified and CAP-accredited labs in California, conforming to the highest quality standards for clinical testing.


  1. Easton, Douglas F., Deborah Ford, and D. Timothy Bishop. "Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium." American journal of human genetics 56.1 (1995): 265.
  2. Petrucelli, Nancie, Mary B. Daly, and Gerald L. Feldman. "BRCA1 and BRCA2 hereditary breast and ovarian cancer." (2013).
  3. Antoniou A, Pharoah PDP, Narod S, et al. Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies. American Journal of Human Genetics. 2003

© 2018 CellMax Life | All Rights Reserved | Terms and Conditions | Privacy Policy